Genocea begins midstage trial of herpes drug to find the right dose

Three weeks after a Genocea Biosciences reported results from an early-stage trial of its most advanced vaccine intended to fight herpes, the Cambridge biotech said today it will start a midstage trial of that drug to hone in on the best dosage level...